학술논문
Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial
Document Type
Artikel
Author
Lipton, JH; Chuah, C; Guerci-Bresler, A; Rosti, G; Simpson, D; Assouline, S; Etienne, G; Nicolini, FE; le Coutre, P; Clark, RE; Stenke, L; Andorsky, D; Oehler, V; Lustgarten, S; Rivera, VM; Clackson, T; Haluska, FG; Baccarani, M; Cortes, JE; Guilhot, F; Hochhaus, A; Hughes, T; Kantarjian, HM; Shah, NP; Talpaz, M; Deininger, MW
Source
The Lancet. Oncology. 17(5):612-621
Subject
Language
English
English
English
ISSN
1474-5488